|
|
|
| home > white papers > Speciality Logistics Outlook 2015 - World Courier |
|
|
 WHITE PAPERS |
|
World Courier
|
|
Speciality Logistics Outlook 2015
|
|
To date, there are more than 178,000 registered clinical trials taking
place across the globe, and global pharma’s volume has more than doubled
over the last decade. With emerging markets showing explosive
predictive growth through 2016, shippers and trial sponsors can expect
continued regulatory and overall logistics complexities that foster
demand for local, inmarket resources across the globe.
|
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
LifeArc Joins Forces with Cystic Fibrosis Trust and Medicines Discovery Catapult to Strengthen Antimicrobial Discovery Efforts
LifeArc, a national medical research charity, is joining the Cystic
Fibrosis (CF) Antimicrobial Resistance (AMR) Syndicate in a strategic
partnership alongside Cystic Fibrosis Trust and Medicines Discovery
Catapult (MDC).
More info >> |
|
 |
White Papers |
 |
|
The Importance of ADCC in Assessing Clinically Relevant Differences
Sartorius Stedim BioOutsource Ltd
Biosimilars have caused a revolution in the development of biologic drugs. The model for biosimilars is a combination of speed to market and low cost; these are fundamental to any biosimilar development project. The biosimilars pathway to approval is not always without difficulty, biosimilars are still relatively new, and as each new applicant is reviewed we are learning more and more about these molecules.
More info >> |
|
|
|
